Is Jean-Claude Junckers decision to move pharmaceuticals out of health and into the Enterprise Directorate a wise one? It has been condemned by health and consumer groups as this means that DG Enterprise will be responsible for promoting EU economic growth through development of the pharmaceutical market in the EU and ensuring that pharmaceuticals are safe. Glenis Willmott, the MEP who steered the 2014 Medical Products Regulation through the Parliament, has called on Mr Juncker to reverse his decision. “This was a bad decision from President Juncker, I hope he will quickly come to his senses and rectify it.” Read more on: bit.ly/1qU7NOe The new commissioner designate for health announced on September 10 is Dr Vytenis Andriukaitis, a member of the Lithuanian Parliament and former Health Minister. His appointment has been welcomed by health campaigners looking for a champion of the concept of “health in all policies.” The European Parliament has the power to veto Commissioner-designates. Hearings will take place in the relevant Parliament committee the week of 29 September to 3 October and the Parliament will vote on the nominees on 21 October. The new Commission is due to start work on 1 November.
Posted on: Tue, 16 Sep 2014 12:41:29 +0000
Trending Topics
Recently Viewed Topics
© 2015